Chen, T.
Mayo Clinic
Clinical Development Acerta Pharma South San Francisco United States
Citations 1
A PHASE 3 STUDY OF ACALABRUTINIB PLUS BENDAMUSTINE AND RITUXIMAB IN ELDERLY (AGED ≥65 Years) TREATMENT‐NAIVE PATIENTS WITH MANTLE CELL LYMPHOMA
Wang, M. , Chu, MH, Dreyling, Martin , Fogliatto, Laura Maria , Inwards, David J. , Mayer, Jiřı́ , Spurgeon, Stephen E. , Yin, Ming , Chen, T., Group, on behalf of the ACE‐LY‐308, Belada, David , Cheah, Chan Y. , Flinn, Ian W. , Goy, Andre Henri , Jurczak, Wojciech , Re, F., Robak, Tadeusz , Yoon, Sung‐Soo , Zinzani, Pier Luigi , Yin, M., Kahl, Brad S. , Group, on behalf of the ACE‐LY‐308
Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 554-555
